HAVCR2 and diffuse large B-cell lymphoma: A recent study in two independent DLBCL cohorts uncovered similar trends in TIM3+LAG3+ TIL abundance in these diseases, and these cells were found to be an independent predictor of poor survival (Autio et al., 2021).